View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

VA RIN: 2900-AQ31 Publication ID: Fall 2019 
Title: Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists 
Abstract:

The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for veterans who are at high risk for overdose or a specific medication or substance in order to reverse the effect of such an overdose. VA is also clarifying that no copayment will be required for the provision of education on the use of opioid antagonists.

 
Agency: Department of Veterans Affairs(VA)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Not subject to, not significant 
CFR Citation: 38 CFR 17.108    38 CFR 17.110   
Legal Authority: Pub. L. 114-198, sec. 915    Pub. L. 114-223, sec. 243    38 U.S.C. 1701    38 U.S.C. 1722A(a)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Final Rule  09/00/2020 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Sandra Mize
Program Analyst (CBO FO)
Department of Veterans Affairs
3773 Cherry Creek North Drive,
Denver, CO 80209
Phone:303 331-7545
Email: sandra.mize@va.gov